simvastatin - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ZEKLEN 10 mg/10 mg ezetimibe 10 mg and simvastatin 10 mg tablet blister pack
AUST R: 233034
Active ingredients:
ezetimibe
simvastatin

Dosage form:
Tablet, uncoated

Sponsor:
ORGANON PHARMA PTY LTD

Phone:
1800023135

Deletion from market:
02 Dec 2024

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

ZEKLEN 10 mg/20 mg ezetimibe 10 mg and simvastatin 20 mg tablet blister pack
AUST R: 232437
Active ingredients:
ezetimibe
simvastatin

Dosage form:
Tablet, uncoated

Sponsor:
ORGANON PHARMA PTY LTD

Phone:
1800023135

Deletion from market:
02 Sep 2024

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

ZEKLEN 10 mg/40 mg ezetimibe 10 mg and simvastatin 40 mg tablet blister pack
AUST R: 232438
Active ingredients:
ezetimibe
simvastatin

Dosage form:
Tablet, uncoated

Sponsor:
ORGANON PHARMA PTY LTD

Phone:
1800023135

Deletion from market:
28 Jun 2024

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

ZEKLEN 10 mg/80 mg ezetimibe 10 mg and simvastatin 80 mg tablet blister pack
AUST R: 232439
Active ingredients:
ezetimibe
simvastatin

Dosage form:
Tablet, uncoated

Sponsor:
ORGANON PHARMA PTY LTD

Phone:
1800023135

Deletion from market:
01 Jul 2024

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability